hymecromone and Cholelithiasis

Topics: Bile Ducts; Cholecystitis; Cholelithiasis; Female; Gallbladder; Humans; Hymecromone; Male; Middle Aged; Ultrasonography; Umbelliferones

The immediate effect of 400 mg mendiaxon was studied in 8 patients with various hepatobiliary diseases. The drug was administered via a duodenal tube in a duodenal drainage tubing according to a minute schedule during the phase of pure bile C secretion. An increased volume was found in all cases. The maximum choleresis exceeds the basal one from 3 to 8 times. The rate of bile flow, in the majority of the patients, was between 2 and 3.3. ml/min. The treatment was carried out on 25 patients in the course of 10 days with a daily dose of 1200 mg (400 mg three times). A good pain-killing effect was obtained. Adverse effects and allergic reactions were not observed. The results from our studies provided grounds to recommend mendiaxon use in the clinical practice.

Topics: Adult; Aged; Biliary Tract Diseases; Cholagogues and Choleretics; Cholecystectomy; Cholecystitis; Cholelithiasis; Female; Humans; Hymecromone; Liver Cirrhosis; Male; Middle Aged; Parasympatholytics; Postoperative Complications; Syndrome; Umbelliferones

Topics: Ampulla of Vater; Biliary Dyskinesia; Biliary Tract Diseases; Cholecystectomy; Cholelithiasis; Drug Evaluation; Humans; Hymecromone; Injections, Intravenous; Postoperative Complications; Sphincter of Oddi; Umbelliferones

Topics: Aged; Ampicillin; Cholelithiasis; Cholestasis; Drug Evaluation; Female; Humans; Hymecromone; Male; Middle Aged; Umbelliferones

Topics: Adult; Bile; Bile Acids and Salts; Cholelithiasis; Cholesterol; Chromatography, Thin Layer; Coumarins; Female; Humans; Hymecromone; Male; Middle Aged